This document provides an overview of pregnancy induced hypertension (PIH), including its definition, risk factors, pathophysiology, clinical features, investigations, complications, and treatment. Some key points:
- PIH complicates 5-10% of pregnancies and is a leading cause of maternal and neonatal morbidity and mortality.
- It is defined as new onset hypertension (blood pressure over 140/90 mmHg) and proteinuria developing after 20 weeks of gestation.
- The pathophysiology involves vasoconstriction due to an imbalance in vasodilators and vasoconstrictors, which can lead to complications like IUGR, preterm birth, and eclampsia.
This topic contains definition, meaning, classification, pathophysiology, clinical menifestations, metabolic and general changes, management of obstetrical shock
This topic contains definition, meaning, classification, pathophysiology, clinical menifestations, metabolic and general changes, management of obstetrical shock
Toxemia of pregnancy: Definition,risk factors,Clinical features,management of pre-eclampsia. Nursing students will understand toxemia of pregnancy .Jasleen Kaur
Toxemia of pregnancy: Definition,risk factors,Clinical features,management of pre-eclampsia. Nursing students will understand toxemia of pregnancy .Jasleen Kaur
Pregnancy-induced hypertension (PIH), also called toxemia or preeclampsia: This condition can cause serious problems for both the mother and the baby if left untreated. PIH develops after the 20th weeks of pregnancy. Along with high blood pressure, it causes protein in the urine, blood changes and other problems.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
4. INTRODUCTION
• Global problem
• Complicates 5-10% of pregnancy
• Responsible for 15-20% maternal mortality
• 20-25% PNM
• Haemodynamic changes are complex
• Risk factors still not well understood
5. defination
• Multysystem disorder
• BP IS RAISED
• Systolic >140 mm of hg
• Diastolic >90 mm of hg
• Asso with proteinuria
• May or may not be asso with edema feet
• Asso with abnormal wt gain
6. physiology
• Progesteron in pregnancy leads to smooth
muscle relaxation
• Results in vasodilatation
• Peripheral resistance falls
• Leads to fall in BP
• THUS BP FALLS IN PREGNANCY
• Instead if it rises it is abnormal-PIH
7. BP
• Systolic >140
• Diastolic>90
• 15 mm rise in diastolic
• 30 mm rise in systolic
• Over the previous readings
• AFTER 20 WK OF GESTATION
• Important to have BP readings in early pregnancy
9. Wt gain
• Normal wt gain during pregnancy is 11kg
• If wt gain is more –could be a sign of PIH
• .>1LB/WK
• >500GM/WK
• Wt gain is due to water retention
• Water retention is due to NA+ RETENTION
• Results in edema all over the body ,specially
feet(dependant part)
11. Mild PIH
• BP-140/90 to 160/110 mm of hg
• Proteinuria<2+
• Asso with abnormal wt gain
• May or may not be asso with edema feet
• NOT ASSO WITH WARNING
SYMPTOMS
12. Severe PIH
• BP>160/110 mm of hg
• Proteinuria>2+
• Abnormal wt gain
• Edema +/-
• Asso with warning symptoms
• Asso with abnormal haematological inv
• oliguria.,DIC,IUFD,jaundice
13. Risk factors
• Genetic predisposition
• Primigravida
• Positive family history
• Vascular ds
• Renal ds
• Poor SES
• Unbooked
• Teenage pregnancy
15. • Normal preg
• BALANCE
BETWEEN VCAND
VD
• Net result is
VASODILATATION
• PIH
• IMBALANCE IN VC
AND VD
• Net result is
VASOCONSTRICTI
ON
16. Results of vasoconstriction
• Reduced blood supply to uterus=IUGR
• Reduced blood supply to kidney=oliguria
• Reduced blood supply to liver=jaundice
• Reduced blood supply to brain=headache
• Reduced blood supply to eyes=blindness
• Reduced blood supply to heart=chest pain
• Reduced blood supply to liver=epigastric pain
17. Results of vasoconstriction
• Decreased intravascular compartment
• Less amount of blood
•Less amount of plasma volume
•Extravasation of excess fluid=edema all over body
•Haemoconcentration
•Rise in disatolic BP
18. Vasocon---
• Genetic/immunologic cause
• Altered prostaglandin ratio
• Elevated thromboxane/prostacyclin ratio-
(TXB2/PGI2)
• ARTERIAL VASOCONSTRICTION
• Rise in vascular tone and vasospasm
• Increase angiotensin2 synthesis-rise in BP
20. Endo injury---
• Endoth injury leads to platlet aggregation
• Platelets get exhausted
•Thrombocytopenia
• New platelets thrown in the circulation
• New pl are more adhesive in nature
• Lead to more pl aggregation
• More thrombocytopenia
21. Endo injury---
• Pl aggregation further reduce the lumen of
BV
• Further depletion in blood supply
• Pl agg results in formation of microthrombi
in minute BV
•INTRAVASCULAR
COAGULATION= = = DIC
27. COMPLI---
• Aim-prevent
• Detect at the earliest
• Treat it timely
• Before it endangers life
• ALL COMPLICATIONS CAN BE
AVOIDED/MINIMISED BY TIMELY
INTERFERENCE
32. • Preterm labor
• PPH
• Deep venous thrombosis
• Pulmonary embolism
• ICH
• Saggital sinus thrombosis
33. T/t
• Principles of mgt
• Control of BP-90-100 DIASTOLIC
• Prevention of complications
• If BP controlled- till term
• If BP not controlled-ignore the fetal
maturity & terminate the pregnancy
34. Control of BP
• Bedrest
• Antihypertensives
• Cap depin-10 mg TDS/QID
• Tab methyldopa-250-500mg TDS/QID
• Tab labetelol-50 mg BD
• HYPERTENSIVE CRISIS- inj labetelol 5-
10 mg slowly